AbCellera Biologics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Vancouver, British Columbia, Canada
ABCL chart
What traders are saying about $ABCL
Latest postsAbCellera Biologics Inc. news
- Did Phase 2 Trial Success Just Shift AbCellera's (ABCL) Investment Narrative?
Simply Wall St ·
- AbCellera Biologics Inc. Stock 12‑Month Price Target Raised to $18, Implies 44% Upside
TradingView ·
- Stifel Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Raises Target Price to $14
Moomoo ·
- AbCellera Biologics Inc. (ABCL) Latest Stock News & Headlines - Yahoo Finance
Yahoo! Finance Canada ·
- AbCellera Biologics Inc (ABCL) (Q3 2026) Earnings Call Highlights: Breakthrough Hot Flash Data ...
Yahoo Finance ·
- Stifel maintains AbCellera Biologics at Buy, raises price target to $14 from $9
TradingView ·
- AbCellera (ABCL) Q3 2026 Earnings Call Transcript
fool.com ·
- AbCellera Biologics (ABCL) Reports Promising Phase II Data and R
GuruFocus ·
- What AbCellera Biologics (ABCL) Said on Its Q3 Earnings Call
marketbeat.com ·
- Is AbCellera Biologics (ABCL) Undervalued On Strong Earnings And Clinical Data?
Simply Wall St ·
- AbCellera Biologics | 10-Q: Quarterly report
Moomoo ·
- AbCellera Biologics Q3FY26 Results: Net loss narrows to $41M, revenue up 11%
scanx.trade ·
AbCellera Biologics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $75.1M | $28.8M | $38.0M | $485.4M |
| Net income | -$146.4M | -$162.9M | -$146.4M | $158.5M |
| Diluted EPS | $-0.49 | $-0.55 | $-0.51 | $0.50 |
| Total assets (year end) | $1.36B | $1.36B | $1.49B | $1.54B |
| Cash and equivalents (year end) | $128.5M | $156.3M | $133.3M | $386.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About AbCellera Biologics Inc.
- Ticker
- ABCL (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Vancouver, British Columbia, Canada
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1703057
Frequently asked questions
What exchange is AbCellera Biologics Inc. listed on?
AbCellera Biologics Inc. trades on the Nasdaq under the ticker symbol ABCL.
What industry is AbCellera Biologics Inc. in?
AbCellera Biologics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is AbCellera Biologics Inc. headquartered?
AbCellera Biologics Inc.'s business address on file with the SEC is in Vancouver, British Columbia, Canada.
When does AbCellera Biologics Inc.'s fiscal year end?
AbCellera Biologics Inc.'s fiscal year ends on December 31.
How much revenue did AbCellera Biologics Inc. report?
AbCellera Biologics Inc. reported $75.1M in revenue for calendar year 2025, according to its SEC filings.